secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADAPTIN BIO, INC. (APTN)
CIK:        0001938571
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001213900-25-096532
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adaptin Bio increases CFO salary to $300k full-time; CDO salary to $150k at 50% commitment
--------------------------------------------------------------------------------

- CFO Timothy Maness moved to full-time from 80%; base salary raised from $240k to $300k, retroactive to July 1, 2025.
- CDO L. Arthur Hewitt commitment increased from 25% to 50%; salary doubled to $150k annually, effective October 3, 2025.
- Hewitt amendment includes anti-dilution option grant if company raises $10M within two years of February 11, 2025 merger.
- Both amendments effective as of specified dates; no other material changes to employment terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938571/000121390025096532/0001213900-25-096532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938571/000121390025096532/ea0260272-8k_adaptin.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-096532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer